| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |